49.42SEK+2.57%Mkt Cap: 1.81B $P/E: —1d ago
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accele…
Indicators:|
Key Statistics
Company
Market Cap1.81B $
Enterprise Value2.21B $
Revenue (TTM)1.60B $
Gross Profit597.73M $
Net Income (TTM)-49.64M $
Revenue/Share4.185 USD
Last Price49.42 SEK
Fiscal Year EndApr 2026
MR QuarterApr 2026
Employees4.4K
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINUS28617Y1010
Valuation
P/E (Trailing)—
P/E (Forward)10.19
PEG0.25
EV/EBITDA16.10
EV/Revenue1.38
P/S1.13
P/B2.66
EPS (TTM)-1.36
EPS (Forward)4.85
52W Range
40.6434% of range66.70
52W High66.70 SEK
52W Low40.64 SEK
Profitability
Gross Margin37.38%
Oper. Margin23.71%
EBITDA Margin8.57%
Profit Margin-3.10%
ROE-7.31%
ROA-1.93%
Growth
Revenue Growth-7.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF235.69M $
CapEx (TTM)102.54M $
FCF Margin6.71%
FCF Yield5.94%
Net Debt396.19M $
Net Debt/EBITDA2.89
Balance Sheet
Debt/Equity1.03
Current Ratio0.87
Quick Ratio0.68
Book Value/Sh18.58 SEK
Cash/Share8.346 SEK
Dividends
Fwd Div Rate2.400 SEK
Trail. Div Rate2.400 SEK
Div. Yield4.86%
5Y Avg Yield3.40%
Payout Ratio315.79%
Ex-Div DateMar 5, 2026
Pay Date—
Splits
Last Split4:1
Split DateSep 12, 2012
Analyst Consensus
Rating3.1 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)59.97 SEK
Upside (mean)+21.3%
Target Range41.00 SEK – 100.00 SEK
SEK41.00+21.3% to meanSEK100.00
# Analysts15
Ownership
Shares Out.367.10M
Float318.66M
Insiders1.93%
Institutions68.44%
Technical
SMA 5054.19 (-8.8%)
SMA 20053.96 (-8.4%)
Beta0.95
S&P 52W Chg20.05%
Avg Vol (30d)1.72M
Avg Vol (10d)1.96M
Technical Indicators
RSI (14)39.2
MACD-2.1087
MACD Signal-1.9085
MACD Hist.-0.2002
BB Upper56.78 SEK
BB Middle51.29 SEK
BB Lower45.79 SEK
BB Width21.43%
ATR (14)1.804 SEK
Vol Ratio (20d)0.41x